UVa Publications on Atrial Fibrillation

Periodicals

  1. Haines DE, Lerman BB, DiMarco JP.  Repetitive supraventricular tachycardia: clinical manifestations and response to therapy with amiodarone.  PACE 9(1 Pt 1):130-3, 1986.
  2. Nath S, DiMarco JP, Mounsey JP, Lobban JH, Haines DE.  Correlation of temperature and pathophysiological effect during radiofrequency catheter ablation of the AV junction.  Circulation 95:1188-92, 1995.
  3. McRury ID, Mitchell MA, Panescu D, Haines DE.  Non-uniform heating during radiofrequency ablation with long electrodes: monitoring the edge effect. .  Circulation 96: 4057-4064, 1997.
  4. Mitchell MA, McRury ID, Haines DE.  Linear atrial ablations in a canine model of chronic atrial fibrillation: morphologic and electrophysiologic observations.  Circulation 97:1176-85, 1998.
  5. Epstein LM, Mitchell MA, Haines DE.  A comparative study of fluoroscopy and intracardiac echocardiographic guidance for the creation of linear atrial lesions.  Circulation 98:1796-1801, 1998.
  6. McRury ID, Mitchell MA, Haines DE.  Efficacy of multiple ring and coil electrode radiofrequency ablation catheters for the creation of long linear lesions in the atria.  Med Engineer Phys 20: 551-557, 1998
  7. Panescu D, Fleischman SD, Whayne JG, Swanson DK, Mirotznik MS, McRury I, Haines DE.  Radiofrequency multielectrode catheter ablation in the atrium.  Phys Med Biol 44: 899-915, 1999.
  8. Mitchell MA, McRury ID, Everett TH, Li H, Mangrum JM, Haines DE. Morphological and physiological characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation. J Cardiovasc Electrophysiol 10: 378-386, 1999.
  9. Everett TH, Li H, Mangrum JM, McRury ID, Mitchell MA, RedickJA, Haines DE.  Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation.  Circulation 102: 1454-1460, 2000.
  10. Mangrum JM, Haines DE, DiMarco JP, Mounsey JP.  Elimination of focal atrial fibrillation with a single radiofrequency ablation:  Use of a basket catheter in a pulmonary vein for computerized activation sequence mapping.  J Cardiovasc Electrophys 2000;11:1159-64.
  11. Everett TH, Moorman JR, Kok L-C, Akar JG, Haines DE. Assessment of global atrial fibrillation organization to optimize the timing of atrial defibrillation.  Circulation 103: 2857-2861, 2001.
  12. Everett TH, Moorman JR, Kok LC, Akar JG, Haines DE. Assessment of global atrial fibrillation organization to optimize timing of atrial defibrillation. Circulation 103:2857-61, 2001.
  13. Everett TH, Li H, Mangrum JM, Mastrangelo C, Haines DE. The effects of atrial electrical remodeling on atrial defibrillation thresholds. PACE 24:1208-15, 2001
  14. Everett TH, Kok L-C, Vaughn R, Moorman JR, Haines DE.  Frequency domain algorithm for quantifying atrial fibrillation organization to increase defibrillation efficacy.  IEEE BME 49: 969-978, 2001.
  15. Mangrum JM, Mounsey JP, Kok LC, DiMarco JP, Haines DE. Intracardiac echocardiography-guided, anatomically based radiofrequency ablation of focal atrial fibrillation originating from pulmonary veins. J Am Coll Cardiol 39:1964-72, 2002.
  16. Kok LC, Mangrum JM, Haines DE, Mounsey JP.  Cerebrovascular complications associated with pulmonary vein ablation.  J Cardiovasc Electrophys 13:764-67, 2002.
  17. Akar JG, Everett TH, Kok LC, Moorman JR, Haines DE. Effect of electrical and structural remodeling on spatiotemporal organization in acute and chronic atrial fibrillation. J Cardiovasc Electrophys 13:1027-34, 2002.
  18. Mangrum JM, Everett TH, Mitchell MA, McRury ID, Li H, Haines DE. The effects of reverse atrial electrical remodeling on atrial defibrillation thresholds. PACE 25:470-6, 2002.
  19. Everett TH, Akar JG, Kok LC, Moorman JR,Haines DE. Use of global atrial fibrillation organization to optimize the success of burst pace termination. J Am Coll Cardiol  40: 1831-1840, 2002.
    20. New England Journal of Medicine 347:1825-33, 2002.
  20. Akar JG, Everett TE, Ho R, Craft J, Haines DE, Somlyo AP, Somlyo AV.  Intracellular chloride accumulation and subcellular elemental distribution during atrial fibrillation.  Circulation 107:1810-5, 2003.
  21. Kok LC, Everett TH, Haines DE.  The effect of heating on pulmonary veins: how do we avoid pulmonary vein stenosis? J Cardiovasc Electrophys 14:250-4, 2003.
  22. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M. Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG.  AFFIRM Investigators.  Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study.  Circulation 109:1509-13, 2004.
  23. Murray KT, Rottman JN, Arbogast PG, Shemanski L, Primm RK, Campbell WB, Solomon AJ, Olgin JE, Wilson MJ, DiMarco JP, Beckman KJ, Dennish G, Naccarelli GV, Ray WA, and the AFFIRM Investigators.   Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM.   Heart Rhythm 1:669-675, 2004.
  24. VerNooy RA, Mangrum JM. Azimilide, a novel oral class III antiarrhythmic for both supraventricular and ventricular arrhythmias. Curr Drug Targets Cardiovasc Haematol Disord 5:75-84, 2005.
  25. Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG. AFFIRM Investigators. Clinical factors that influence response to treatment strategies in atrial fibrillation:   The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 149(4):645-9, April 2005.
  26. DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, and the AFFIRM Investigators.   Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.   Am Heart J 149(4):650-6, April 2004.
  27. Mason PK, Wood MA, Lake D, DiMarco JP.   Influence of the randomized trials, AFFIRM and RACE, on the management of atrial fibrillation in two university medical centers. Am J Cardiol 15;95(10):1248-50, May 2005.
  28. Sherman DG, Kim SG, Boop BS, Corley SD, DiMarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL, for the National Heart, Lung, and Blood Institute AFFIRM Investigators.   Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study. Arch Intern Med 165(10):1185-91, May 23 2005.
  29. Bunch TJ, Bruce GK, Mahapatra S, Johnson S, Miller D, Sarabanda A, Milton M, Packer DL. Ablation at the pulmonary mechanisms of phrenic nerve injury during radiofrequency vein orifice. Journal of Clinical Electrophysiology, August 2005.
  30. Sarabanda A, Bunch TJ, Johnson SB, Mahapatra S, Milton MA, Luiz L, Bruce G, Packer DL. Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. J Am Coll Cardiology46(10):1902-12, 2005.
  31. Hamdan MH, Freedman RA, Gilbert EM, Dimarco JP, Ellenbogen KA, Page RL. Atrioventricular junction ablation followed by resynchronization therapy in patients with congestive heart failure and atrial fibrillation (AVERT-AF) study design. Pacing Clin Electrophysiol 29(10):1081-8, October 2006.

Book Chapters, Invited Articles, Editorials

  1. DiMarco JP.  Surgical therapy for atrial fibrillation:  a first step on what may be a long road.  J Am Coll Cardiol 17:976-7, 1991. (editorial) 
  2. DiMarco JP.  Further evidence in support of anticoagulant therapy before elective cardioversion of atrial fibrillation.  J Am Coll Cardiol 19:856-7, 1992. (editorial) 
  3. DiMarco JP.  Pharmacologic management of atrial fibrillation.  Cardiology in the Elderly 1(2):170-175, 1993. 
  4. Jung F, DiMarco JP.  Antiarrhythmic drug therapy in the treatment of atrial fibrillation.  Cardiology Clinics 14:507-20, 1996. 
  5. Murgatroyd FD, Haines DE, Swartz JF.  Catheter ablation as a curative approach to the substrate of atrial fibrillation.  In:  Nonpharmological management of atrial fibrillation.  Murgatroyd FD, Camm AJ, editors.  Armonk, N.Y.: Futura Publishing, 1997, pp. 239-256. 
  6. Jung F, DiMarco JP.  Treatment strategies for atrial fibrillation.  American Journal of Medicine 104:272-86, 1998. 
  7. Mangrum JM, Haines DE. New catheter technologies for ablation of atrial fibrillation. In:  Radiofrequency Catheter Ablation of Cardiac Arrhythmias:  Basic Concepts & Clinical Applications, 2nd Edition.  Huang SK, Wilber DJ, editors.  Armonk, NY: Futura, 2000, 367-386.
  8. Mounsey JP, DiMarco JP.  Cardiovascular drugs.  Dofetilide.  Circulation 102:2665-70, 2000.
  9. DiMarco JP.  Selective vagal stimulation for rate control in atrial fibrillation.  Circulation 106:1746-7, 2002. (editorial)
  10. Lip GYH, Mangrum JM, DiMarco JP.  Atrial Fibrillation. In Cardiology. Edited by DiMarco, JP and Crawford M. Mosby International 2004;699-716.
  11. VerNooy RA, Mounsey JP.  Antiarrhythmic drug therapy of atrial fibrillation.  Cardiology Clinics.  22:21-34, 2004.
  12. VerNooy RA.  Mangrum JM.  Azimilide, a Novel Class III Antiarrhythmic, for both Supraventricular and Ventricualr Arrhythmias.   Current Drug Targets—Cardiovascular and Haematological Disorders.  (Accepted)
  13. DiMarco JP, Gersh BJ, Opie LH.   Antiarrhythmic drugs and strategies.   In:   Drugs for the Heart, 6th ed.   Opie LH, Gersh BJ, eds.   Elsevier/Saunders, Philadelphia, 2005, pp 218-274.
  14. Mangrum JM. Atrial Fibrillation Expert Column: Arial fibrillation in patients with left ventricular dysfunction and heart failure: What have we learned to date? Medscape 2006. http://www.medscape.com/viewarticle/530724
  15. Mangrum JM, FergusonJD, DiMarco JP.   Acute and chronic pharmacologic management of supraventricular tachycardias.   In:   Cardiovascular Therapeutics.   A Companion to Braunwald’s Heart Disease, 3rd ed.   Antman EM, ed.   W.B. Saunders/Elsevier, Philadelphia, 2007, pp 481-488.
  16. Mangrum JM and Greenbaum H. Spotlight Interview: University of Virginia’s Atrial Fibrillation Center. EP Digest October 2006, pp 12-14, 17.
Abstracts
  1. Haines DE, McRury IA, Whayne JG, Fleischman SD.  Atrial radiofrequency ablation:  the use of a novel deploying loop catheter design to create long linear lesions.  Circulation 90:I-335, 1994.
  2. McRury IA, Whayne JG, Fleischman SD, Haines DE.  What are the power requirements for radiofrequency ablation with multielectrode catheters in the atrium?  Circulation 90:I-336, 1994.
  3. Mitchell MA, Ackerman SJ, Nath S, Haines DE, DiMarco JP.  Natural history of atrial rhythm after atrioventricular junctional ablation.  PACE 18:1995.
  4. Whayne JG, Haines DE, Panescu D, Fleischman SD, McRury ID, Mitchell MA, Swanson DK.  Catheter systems designed to facilitate RF ablation of atrial fibrillation.  PACE 19:650, 1996.
  5. Mitchell MA, McRury ID, Haines DE.  Prevention of coagulum formation during radiofrequency ablation with long electrodes: the importance of the edge effect.  Circulation 94:I-6, 1996.
  6. Whayne JG, Haines DE, Panescu D, Fleischman SD, McRury ID, Mitchell MA, Swanson DK. Ring and coil electrodes for ablation of atrial fibrillation. Circulation 94:I-127, 1996.
  7. Panescu D, Haines DE, Fleischman SD, Whayne JG, McRury ID, Swanson DK.  Atrial lesions by temperature-controlled radiofrequency ablation.  Circulation 94:I-493, 1996.
  8. Mitchell MA, McRury ID, Haines DE.  Anatomic determinants of atrial fibrillation cycle length in canines with chronic atrial fibrillation.  J Am Coll Cardiol 29:359A, 1997.
  9. Epstein LM, Mitchell MA, Smith TW, Haines DE.  Intracardiac echocardiographic guidance improves positioning and continuity of linear right atrial lesions. PACE 20:1055, 1997.
  10. Mitchell MA, McRury ID, Haines DE.  Atrial defibrillation thresholds decrease during reverse electrical remodeling. PACE 20:1057, 1997.
  11. Greeenspon AJ, Hsu SS, Haines DE, Chilson D.  Endocardial mapping and ablation guided by a multielectrode “basket” catheter.  PACE 20:1076, 1997.
  12. Mitchell MA, McRury ID, Haines DE.  Morphologic and physiologic characteristics of discontinuous linear atrial ablations during atrial pacing and atrial fibrillation.  PACE 20:1100, 1997.
  13. McRury ID, Mitchell MA, Haines DE.  Natural history of chronic atrial fibrillation in canines: fibrillation despite reverse electrical remodeling.  PACE 20:11155, 1997.
  14. Mitchell MA, Hughes GS, Ellenbogen KA, Leonard LB, Dietrich C, Sargent DA, Tschinkel MB, Wood MA, DiMarco JP.  Cardioversion related stroke rates in atrial fibrillation and atrial flutter.  Circulation 96:I-453, 1997.
  15. Haines DE McRury ID, Mitchell MA.  Effects of linear atrial ablation on spatial organization of fibrillating atria.  Circulation 96:I-259, 1997.
  16. Everett T, Li H, Mangrum JM, Haines DE.  Atrial defibrillation thresholds are not time dependent with 60 minutes of atrial fibrillation onset.  PACE 21:II-807, 1998.
  17. Haines DE, Langberg JJ, Lesh MD, Leon AR, Mitchell MD, DeLurgio DB.  Catheter ablation of atrial fibrillation using the multiple electrode catheter ablation (MECA) system: preliminary clinical trial results. PACE 21:II-832, 1998.
  18. Kok LC, Rohleder A, Haines DE.  Bradycardia-dependent onset of paroxysmal atrial fibrillation is uncommon.  Circulation 98:I-18, 1998.
  19. Mangrum JM, Li Hui, Everett TH, Haines DE.  Morphological remodeling, not electrical remodeling, dominates vulnerability to atrial fibrillation. Circulation 98:I-684, 1998.
  20. Everett TH, Moorman JR, Haines DE.  Predication of successful intra-atrial defibrillation by analysis of atrial fibrillation waveform. Circulation 98:I-712, 1998.
  21. Everett TH, Li H, Mangrum JM, Haines DE.  Time dependency of atrial electrical remodeling and atrial defibrillation thresholds.  PACE 22:826, 1999.
  22. Everett TH, Moorman JR, Haines DE.  What is the optimal sampling window for analysis of an intra-atrial fibrillation waveform to predict cardioversion efficacy?  PACE 22:851, 1999.
  23. Mangrum JM, Everett TH, Li H, Redick J, Haines DE.  Atrial myolysis is independent of reverse electrical remodeling.  PACE 22:882, 1999.
  24. Mangrum JM, Everett TH, Li H, Panescu D, Haines DE.  Epicardial radiofrequency atrial lesions: finite element analysis and in-vivo study of a new surgical approach.  Circulation 100:I-65, 1999.
  25. Everett TH, Kok LC, Moorman JR, Haines DE.  Increased cardioversion efficacy with shocks timed to increased measured levels of atrial fibrillation organization.  Circulation 100:I-70, 1999.
  26. Mangrum JM, Everett TH, Kok LC, Shang L, Haines DE.  Atrial mechanoelectric feedback in a chronic dog model: stretch dominates stress in atrial fibrillation vulnerability.  Circulation 100:I-341, 1999.
  27. Everett TH, Shang L, Mangrum JM, Haines DE.  Atrial fibrillation signal conduction in the left atrium is a 2-dimensional phenomenon.  Circulation 100:I-341, 1999.
  28. Everett TH, Moorman JR, Kok LC, Haines DE.  Assessment of global atrial fibrillation organization to optimize the timing of atrial defibrillation.  J Am Coll Cardiol 35:546A, 2000.
  29. Kok LC, Everett TH, Haines DE.  The effect of heating on pulmonary veins: how do we avoid pulmonary vein stenosis?  PACE 23: II-562, 2000.
  30. Everett TH, Mangrum JM, Li H, Haines DE.  Premature atrial contractions decrease with reverse atrial electrophysiological remodeling but vulnerability persists.  PACE 23: II-158, 2000.
  31. Haines DE, Hummel JD, Kalbfleisch SJ, Daoud EG, Avital B, Langberg JJ, Leon AR, Epstein LM.  Bi-atrial linear ablation with the multiple electrode catheter ablation (MECA) system in patients with atrial fibrillation.  PACE 23: II-567, 2000.
  32. Mangrum JM, Mounsey JP, DiMarco JP, Haines DE.  Intracardiac echocardiography-guided, anatomically-based ablation of focal atrial fibrillation originating from pulmonary veins.  PACE 23; II-625, 2000.
  33. Mangrum JM, Mounsey JP, DiMarco JP, Haines DE.  The immediate effects of radiofrequency ablation on pulmonary veins.  Circulation 102: II-368, 2000.
  34. Mangrum JM, DiMarco JP, Haines DE, Mounsey JP.  Focal atrial fibrillation and the use of a basket catheter in a pulmonary vein for computerized 3-dimensional activation sequence mapping.  Circulation 102: II-483, 2000.
  35. Mangrum JM, DiMarco JP, Haines DE, Mounsey JP.  The use of a new 3-dimensional mapping system for atrial dysrhythmias.  Circulation 102: II-618, 2000.
  36. Akar JG, Everett TH, Kok LC, MacDonald T, Szabo G, Haines DE.  Prevention and reversal of electrical remodeling in atrial fibrillation by TH1177, a novel calcium channel antagonist.  J Am Coll Cardiol 37: 92A, 2001.
  37. Everett TH, Mangrum JM, DiMarco JP , Moorman JR, Haines DE.  Loss of spatiotemporal organization with the transition from acute to chronic atrial fibrillation in vivo.  J Am Coll Cardiol 37: 127A, 2001.
  38. Akar JG, Everett TH, Kok LC, Moorman JR, Haines DE. Prediction of successful external cardioversion of atrial fibrillation by frequency domain analysis of a surface electrogram.  PACE 24: II-585, 2001.
  39. Haines DE, Gabbard J, Wolf R, Damiano RJ.  Rapid, continuous and transmural linear ablation with a novel bipolar radiofrequency ablation system.  PACE 24: II-608, 2001.
  40. Kok LC, Mounsey JP, Haines DE, DiMarco JP, Mangrum JM.  Conduction pattern in arrhythmogenic pulmonary veins in patients with focal atrial fibrillation.  PACE 24: II-655, 2001.
  41. Akar JG, Everett TH, Moorman JR, Haines DE.  Effect of structural and electrical remodeling on spatiotemporal organization in the transition from acute to chronic atrial fibrillation.  PACE 24: II-668, 2001.
  42. Everett TH, Akar JG, Kok LC, Moorman JR, Haines DE.  Assessment of global atrial fibrillation organization to optimize the timing of burst pace termination.  PACE 24: II-684, 2001.
  43. Mangrum JM,, Everett TH, Kok LC, Shang L, Haines DE.  Atrial mechanoelectric feedback: does mitral regurgitation decrease atrial fibrillation vulnerability?  PACE 24: II-690, 2001.
  44. Everett TH, Mangrum JM, DiMarco JP, Moorman JR, Haines DE.  Prediction of successful external cardioversion of atrial fibrillation by frequency domain analysis of a surface electrogram. PACE 24: II-585, 2001.
  45. Miles RD, Dimarco JP, Haines DE, Mounsey JP, Mangrum JM.  Radiofrequency ablation of pulmonary veins with intracardiac echo guidance for atrial fibrillation: analysis of clinical and echocardiographic predictors of recurrence.  Circulation 104:II-620, 2001.
  46. Akar JG, Ho R, Everett TH, Haines DE, Somlyo AP, Somlyo AV.  What is the role of intracellular chloride accumulation in atrial fibrillation?  PACE 25:626, 2002.
  47. Haines DE, Hummel JD, Knight BP, Moulton KP, MECA Investigators. Linear atrial ablation with the multiple electrode catheter ablation (MECA) system for atrial fibrillation: final report.  PACE 25:637, 2002.
  48. Akar J, Everett TH, Ho R, Haines DE, Somlyo AP, Somlyo AV.  Early cell swelling and intracellular chloride accumulation following atrial pacing.  Circulation 106: II-154, 2002.
  49. Mangrum JM, Sih HJ, Molloy J, Akar JG, Mourtada F, Rippy MK, Read PW, Everett TH, Haines DE.  Beta radiation for pulmonary vein isolation.  Circulation 106 II-630, 2002.
  50. Hummel JP, Ferguson JD, Mangrum JM, Finta B, DiMarco JP, Haines DE, Mounsey JP.  Pulmonary Vein Isolation in Focal Atrial Fibrillation:  A Prospective Randomized Comparison of Anatomical Versus Map-Guided Ablation.  PACE 26:962, 2003.
  51. Mangrum JM, Hummel JP, Finta B, Haines DE, Kok LC, DiMarco JP, Ferguson JD, Akar J, Natarajan S, Mounsey JP.  Comparison Between Selective Versus Empiric Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation.  Circulation 108:IV-618, 2003.
  52. Hummel JP, Mangrum JM, Ferguson JD, Akar JG, Natarajan S, DiMarco JP, Mounsey JP.  Long-Term Results of an Anatomic Approach to Pulmonary Vein Isolation Using Intracardiac Echo Guidance.  Heart Rhythm 1:S230, 2004.
  53. Ferguson JD, Helms AS, Hummel JP, Mounsey JP, DiMarco JP, Mangrum JM. Real-Time Intra-cardiac Ultrasound Imaging of the Ablation Catheter's Relation to the Esophagus During Left Atrial Ablation. Circulation 112: II-555, 2005.
  54. Helms AS, Hummel JP, Mangrum JM, Mounsey JP, DiMarco JP, Ferguson JD. A Prospective Evaluation of Side-by-Side 3D Images Added to Non-Fluroscopic Mapping of the Left Atrium: Effect on Spatial Resolution and Procedure Time. Circulation 112: II-573, 2005.
  55. VerNooy RA, Hummel JP, Kramer C, Voros S, Mangrum JM, DiMarco JP, Mounsey JP, Ferguson JD.  Real-time intracardiac echocardiographic monitoring during circumferential pulmonary vein isolation to identify acute pulmonary vein. Circulation 110: III-349-350, 2004.
  56. Prudente LP, Ferguson JD, Mounsey JP, DiMarco JP, Hummel JP, Clark A, VerNooy RA, Mangrum JM. Gender-based clinical outcomes for atrial fibrillation ablation.  Heart Rhythm 2: S25-S26, 2005.
  57. Russell CL, Prudente LP, Ferguson JD, Mounsey JP, Hummel JP, DiMarco JP, Mangrum JM.  Anticoagulation during atrial fibrillation ablation. Heart Rhythm 2: S26, 2005.
  58. Hummel JP, Mounsey JP, Mangrum JM, DiMarco JP, Ferguson JD. Assessment of left atrial linear block during ablation for atrial fibrillation using a noncontact mapping system.  Heart Rhythm 2: S312-S313, 2005.
  59. Mason PK, Wood MA, Lake D, DiMarco JP.   Do randomized trials affect clinical practice? AFFIRM, RACE, and the management of atrial fibrillation. J Am Coll Cardiol 43(5, suppl A):150A-151A, March 2004. (#875-2)
  60. Hummel JP, Mangrum JM, Ferguson JD, Akar JG, Natarajan S, DiMarco JP, Mounsey JP. Long-term results of an anatomical approach to pulmonary vein isolation. Heart Rhythm 1:S22, 2004.
  61. Bunch TJ, Bruce GK, Mahapatra S, Johnson SB, Miller DV, Milton MA, Sarabanda A, Packer DL. Mechanisms of phrenic nerve injury during radiofrequency ablation at the pulmonary vein orifice. Heart Rhythm 2:S95, May 2005.
  62. Mahapatra S, Holmes DR, Jr., Peterson LA, Monahan KH, Packer DL. Pulmonary venous collateral development partially explains improved symptoms in severely symptomatic pulmonary vein stenosis patients Heart Rhythm 2:S153-S154, May 2005.
  63. Prudente LA, Mangrum JM, Greenbaum H, Lake DE, Xiao Y, Hummel JP, Mounsey JP, Ferguson JD, Dimarco JP, Moorman JR. Model for predicting resource utilization in clinics
    64. treating atrial fibrillation. Heart Rhythm 2006; 3:S35.
  64. Budge LP, Isbell DC, Moorman JR, Lake DE, Mangrum JM. Imaging of the left atrial appendage in patients with atrial fibrillation: A comparison of TEE and cardiac CT. Heart Rhythm 3:S128, 2006.
  65. Ferguson JD, Mounsey JP, Mangrum JM, DiMarco JP, Hummel JP. Intracardiac echo imaging of the relationship of esophagus to mitral isthmus during linear ablation. Heart Rhythm 3:S124-S125, 2006.